AdBio Partners
2 rounds tracked since 7 July 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $37.2M
Sectors
Countries
Rounds
- Integra TherapeuticsFiCAT gene writing platform combining CRISPR accuracy with a transposase $12.5MVenture · 8 Sept
- EvlaBioBiotech developing an antibody for left ventricular hypertrophy in chronic kidney disease. $24.6MSeed · 7 Jul
No round matches these filters.